C

Curacle Co Ltd
KOSDAQ:365270

Watchlist Manager
Curacle Co Ltd
KOSDAQ:365270
Watchlist
Price: 9 600 KRW 8.23% Market Closed
Market Cap: ₩201.7B

Operating Margin

-1 218.9%
Current
Declining
by 666%
vs 3-y average of -552.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 218.9%
=
Operating Income
₩-13.9B
/
Revenue
₩1.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 218.9%
=
Operating Income
₩-13.9B
/
Revenue
₩1.1B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Curacle Co Ltd
KOSDAQ:365270
201.7B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Lower than 99% of companies in Korea
Percentile
1st
Based on 2 615 companies
1st percentile
-1 218.9%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Curacle Co Ltd
Glance View

Market Cap
201.7B KRW
Industry
Biotechnology

Curacle Co., Ltd. is engaged in the business of research and experimental development on medical sciences and pharmacy. The company is headquartered in Seoul, Seoul and currently employs 39 full-time employees. The company went IPO on 2021-07-22. The firm researches and develops synthetic drugs CU06-RE, CU01, and natural drug CU03 as new drugs for intractable vascular diseases. The Company’s drugs are used for diabetic macular edema (DME), diabetic nephropathy (DN), and wet age-related macular degeneration (wet AMD). In addition, the Company uses the SOLVADYS platform technology, a platform technology for the development of vascular endothelial dysfunction blockers.

Curacle Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 218.9%
=
Operating Income
₩-13.9B
/
Revenue
₩1.1B
What is Curacle Co Ltd's current Operating Margin?

The current Operating Margin for Curacle Co Ltd is -1 218.9%, which is below its 3-year median of -552.9%.

How has Operating Margin changed over time?

Over the last 3 years, Curacle Co Ltd’s Operating Margin has decreased from -67.4% to -1 218.9%. During this period, it reached a low of -1 294.1% on Jun 30, 2025 and a high of -67.4% on Aug 30, 2022.

Back to Top